Cochran Firm Wisconsin Reacts to CBC Report on ‘Suspected’ Role of Yaz and Yasmin in Deaths from Blood Clots

Will Techmeier of the Cochran Firm Wisconsin LLP says the firm has added new content to its website to provide concerned consumers and their families with general information about the Yaz and Yasmin birth control pills.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Attorney comments on CBC report concerning Yaz and Yasmin birth control pills

Will Techmeier

When news reports or FDA information concerning risks associated with particular drugs emerges, consumers of those drugs will have questions about their legal rights.

Milwaukee, WI (PRWEB) June 15, 2013

Will Techmeier, the senior partner of the Cochran Firm Wisconsin LLP, said his law firm is alarmed by a recent news report on the “suspected” connection between the Yaz and Yasmin birth control pills and the deaths of 23 Canadian women. The report may raise questions among U.S. consumers, the attorney said.

Techmeier referred to the June 12, 2013 article on the Canadian Broadcasting Corporation (CBC) news website entitled, “Yaz, Yasmin birth control pills suspected in 23 deaths.”

The report, citing documents obtained from Health Canada, states that “between 2007 and February 2013, doctors and pharmacists have reported 600 adverse reactions and 23 deaths where Yaz or Yasmin were suspected. More than half of the reported deaths were women under 26, with the youngest age 14.”

The report goes on to state that most of the women “died suddenly from blood clots.” Copies of the Health Canada documents cited in the report can be found on the CBC website, accompanying the article.

“This is a very alarming report, to say the least, and it should capture the attention of any past or present Yaz or Yasmin birth control users in Wisconsin,” Techmeier said. “This report reflects concerns that have been raised in the U.S. about these products.”

Techmeier pointed to an April 2012 U.S. Food and Drug Administration (FDA) safety communication about drospirenone-containing birth control pills, including Yaz and Yasmin. The FDA stated that, based on its review of observational studies, the agency had “concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots [deep vein thrombosis or pulmonary embolism] than other progestin-containing pills.”

“When news reports or FDA information concerning risks associated with particular drugs emerges, consumers of those drugs will have questions about their legal rights,” Techmeier said. “It’s important for those consumers to speak with an attorney who can review their situation and explain their rights and options.”

According to Techmeier, the Cochran Firm Wisconsin recently added new content to its website to provide general information for concerned consumers and their families about Yaz / Yasmin side effects.

“While a website can be helpful, it’s no substitute for talking directly with an attorney about the specific facts and circumstances of one’s own unique situation,” Techmeier said. “Our firm facilitates this discussion by offering free and confidential consultations.”

About The Cochran Firm Wisconsin LLP

The attorneys of the Cochran Firm Wisconsin LLP have more than 60 combined years of professional experience in helping accident and injury victims in Milwaukee and throughout Wisconsin, including those harmed by dangerous drugs and other defective medical products.

The firm’s office is located at The Renaissance on Water Street, Suite 160, 309 North Water St., Milwaukee, WI 53202 (local phone 414-223-1050). For more information, call the firm toll free at (888) 974-0628 or use the firm’s online form.